ZANITA

Allergan Sales, Llc

Application Filed: 2014-06-20

Trademark Application Details

Status

606

Dead/Abandoned

ABANDONED - NO STATEMENT OF USE FILED

Research	OneLook Acronym Finder
Serial Number	86315803
Mark Drawing Code	4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Attorney Name	Matthew O. Brady
Attorney Docket Number	ZAN001
Law Office Assigned	L30
Employee Name	STRINGER, DANIEL S

Timeline

2014-06-20	Application Filed
2014-11-25	Published for Opposition
2016-02-23	Location: INTENT TO USE SECTION
2017-08-21	Abandon
2017-08-21	Status: Dead/Abandoned
2018-07-08	Transaction Date

Trademark Applicants & Owners

Owner:	ALLERGAN SALES, LLC
Address	5 GIRALDA FARMS MADISON DE 07940
Legal Entity Type	Limited Liability Company
Legal Entity State	DE

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

MATTHEW O. BRADY
Allergan, Inc.
2525 Dupont Drive
Irvine CA 92612

Good, Services, and Codes

International Codes:	5
U.S. Codes:	006,018,044,046,051,052

Type Code	Type
GS0051	Contraceptive preparations; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines for the sensory organs; Pharmaceuticals and medicines for the central nervous system; Pharmaceuticals and medicines for the urogenital organs; Pharmaceuticals and medicines for the circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular diseases and blood pressure; Pharmaceuticals preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antimicrobial preparations for inhibiting microbiological decomposition in pharmaceuticals

Type Code

Type

GS0051

Contraceptive preparations; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines for the sensory organs; Pharmaceuticals and medicines for the central nervous system; Pharmaceuticals and medicines for the urogenital organs; Pharmaceuticals and medicines for the circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular diseases and blood pressure; Pharmaceuticals preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antimicrobial preparations for inhibiting microbiological decomposition in pharmaceuticals

Trademark Filing History

Description	Date	Event Coding
NEW APPLICATION ENTERED IN TRAM	2014-06-24	1 NWAP I:Incoming Correspondence
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	2014-06-28	2 NWOS I:Incoming Correspondence
ASSIGNED TO EXAMINER	2014-09-24	3 DOCK D:Assigned to Examiner
EXAMINERS AMENDMENT -WRITTEN	2014-10-01	4 CNEA R:Renewal
EXAMINERS AMENDMENT E-MAILED	2014-10-01	5 GNEA F:First Action
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED	2014-10-01	6 GNEN O:Outgoing Correspondence
EXAMINER'S AMENDMENT ENTERED	2014-10-01	7 XAEC I:Incoming Correspondence
APPROVED FOR PUB - PRINCIPAL REGISTER	2014-10-01	8 CNSA P:
ASSIGNED TO LIE	2014-10-22	9 ALIE A:Allowance for Publication
LAW OFFICE PUBLICATION REVIEW COMPLETED	2014-10-22	10 PREV O:Outgoing Correspondence
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	2014-11-05	11 NONP E:E-Mail
PUBLISHED FOR OPPOSITION	2014-11-25	12 PUBO A:Allowance for Publication
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	2014-11-25	13 NPUB E:E-Mail
NOA E-MAILED - SOU REQUIRED FROM APPLICANT	2015-01-20	14 NOAM E:E-Mail
TEAS EXTENSION RECEIVED	2015-07-20	15 EEXT I:Incoming Correspondence
EXTENSION 1 FILED	2015-07-20	16 EXT1 S:
EXTENSION 1 GRANTED	2015-07-20	17 EX1G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2015-07-22	18 EXRA E:E-Mail
TEAS EXTENSION RECEIVED	2016-01-20	19 EEXT I:Incoming Correspondence
CASE ASSIGNED TO INTENT TO USE PARALEGAL	2016-02-23	20 AITU A:Allowance for Publication
EXTENSION 2 FILED	2016-01-20	21 EXT2 S:
EXTENSION 2 GRANTED	2016-02-26	22 EX2G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2016-02-27	23 EXRA E:E-Mail
TEAS EXTENSION RECEIVED	2016-07-19	24 EEXT I:Incoming Correspondence
EXTENSION 3 FILED	2016-07-19	25 EXT3 S:
EXTENSION 3 GRANTED	2016-08-01	26 EX3G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2016-08-02	27 EXRA E:E-Mail
TEAS EXTENSION RECEIVED	2017-01-10	28 EEXT I:Incoming Correspondence
EXTENSION 4 FILED	2017-01-10	29 EXT4 S:
EXTENSION 4 GRANTED	2017-01-10	30 EX4G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2017-01-12	31 EXRA E:E-Mail
TEAS CHANGE OF CORRESPONDENCE RECEIVED	2017-01-30	32 TCCA I:Incoming Correspondence
ABANDONMENT - NO USE STATEMENT FILED	2017-08-21	33 ABN6 S:
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED	2017-08-21	34 MAB6 O:Outgoing Correspondence
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP	2018-01-03	35 ASGN I:Incoming Correspondence

Similar Marks

Mark Image Registration \| Serial	Company Trademark Application Date
ZANITA 90459413 not registered Live/Pending	Allergan Sales, LLC 2021-01-11
ZANITA 87522246 not registered Live/Pending	Allergan Finance, LLC 2017-07-10
ZANITA 86315803 not registered Dead/Abandoned	ALLERGAN SALES, LLC 2014-06-20
ZANITA 85184924 not registered Dead/Abandoned	ALLERGAN SALES, LLC 2010-11-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.